Skip to main content

Search Results for

“telegram老频道购买✅SMMFS.COM✅拉人代开会员,MrU”

July 25, 2019

VIDEO SERIES ON EXERCISE AND OSTEOPOROSIS Osteoporosis Canada has developed a video series on exercise and osteoporosis in partnership with the University of Waterloo and Geriatric Education and Research in […]

December 5, 2012

There has been recent media coverage concerning a rare atypical femoral fracture that may be a side effect of denosumab (Prolia), an osteoporosis medication manufactured by Amgen. Osteoporosis Canada’s Scientific […]

November 27, 2012

An atypical femoral fracture is an uncommon type of hip fracture which has been associated with long term use of certain osteoporosis medications. This type of hip fracture affects the […]

October 29, 2021

On behalf of Osteoporosis Canada’s Scientific Advisory Consultants and Osteoporosis Canada, we would like to announce this year’s Lindy Fraser Award winner as chosen by the members of the SAC. […]

June 7, 2019

Board of Directors Jeannette Briggs Chair | Oakville, ON Jeannette has more than 25 years of experience working in the energy sector.  She has held a wide-range of jobs within […]

May 25, 2020

Members of Osteoporosis Canada’s Scientific Advisory Council would like announce this year’s Lindy Fraser Award winner as chosen by the members of the SAC. Osteoporosis Canada established this award in 1993 […]

June 15, 2012

We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]

June 27, 2012

We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]

© Osteoporosis Canada, 2024
Charitable Registration No. 89551 0931 RR 0001